Marc Stapley Veracyte, Inc. (VCYT) insider trading activity

Marc Stapley is Chief Executive Officer of VERACYTE, INC.. Currently has a direct ownership of 358,636 shares of VCYT, which is worth approximately $11.4 Million. The most recent transaction as insider was on Mar 06, 2025, when has been sold 90,601 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 359K

16.69% 3M change

8.76% 12M change

Total Value Held $11.4 Million

Marc Stapley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2025	BUY Grant, award, or other acquisition	-	90,601 Added 20.17%	358,636 Common Stock
Mar 04 2025	SELL Open market or private sale	$1,775,888 $33.7 p/Share	52,697 Reduced 16.43%	268,035 Common Stock
Mar 02 2025	SELL Payment of exercise price or tax liability	$706,462 $34.76 p/Share	20,324 Reduced 5.96%	320,732 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$1,159,798 $33.84 p/Share	34,273 Reduced 9.13%	341,056 Common Stock
Feb 27 2025	BUY Grant, award, or other acquisition	-	67,277 Added 15.2%	375,329 Common Stock
Dec 13 2024	SELL Open market or private sale	$244,562 $43.75 p/Share	5,590 Reduced 1.79%	307,345 Common Stock
Dec 02 2024	SELL Payment of exercise price or tax liability	$253,601 $44.12 p/Share	5,748 Reduced 1.8%	312,935 Common Stock
Sep 02 2024	SELL Payment of exercise price or tax liability	$181,349 $31.55 p/Share	5,748 Reduced 1.77%	318,683 Common Stock
Jun 02 2024	SELL Payment of exercise price or tax liability	$119,229 $20.75 p/Share	5,746 Reduced 1.74%	323,994 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$125,988 $21.1 p/Share	5,971 Reduced 1.78%	329,740 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	11,780 Added 3.39%	335,711 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	114,724 Added 26.15%	323,931 Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$318,864 $24.0 p/Share	13,286 Reduced 5.97%	209,207 Common Stock
Dec 02 2023	SELL Payment of exercise price or tax liability	$85,007 $26.54 p/Share	3,203 Reduced 1.42%	221,882 Common Stock
Sep 02 2023	SELL Payment of exercise price or tax liability	$85,546 $26.7 p/Share	3,204 Reduced 1.4%	225,085 Common Stock
Jun 02 2023	SELL Payment of exercise price or tax liability	$85,584 $26.72 p/Share	3,203 Reduced 1.39%	227,696 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	78,044 Added 25.26%	230,899 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$145,298 $24.1 p/Share	6,029 Reduced 3.79%	152,855 Common Stock
Dec 02 2022	SELL Payment of exercise price or tax liability	$29,489 $29.14 p/Share	1,012 Reduced 0.64%	158,299 Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$19,410 $19.18 p/Share	1,012 Reduced 0.63%	159,311 Common Stock
Jun 10 2022	BUY Open market or private purchase	$979,800 $16.33 p/Share	60,000 Added 27.3%	159,761 Common Stock
Jun 02 2022	SELL Payment of exercise price or tax liability	$73,777 $18.23 p/Share	4,047 Reduced 3.9%	99,761 Common Stock
Mar 03 2022	BUY Grant, award, or other acquisition	-	56,537 Added 35.26%	103,808 Common Stock
Jun 01 2021	BUY Grant, award, or other acquisition	-	46,807 Added 50.0%	46,807 Common Stock

Also insider at

GKOS

GLAUKOS Corp Healthcare

Marc Stapley

Chief Executive Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCYT shares.

Notify only if

Value

Insider Trading

Get notified when an Veracyte, Inc. insider buys or sells VCYT shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERACYTE, INC.

Track Activities on VCYT

Account